Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A pill bottle and scattered pills on a pharmacy shelf in dim light.

Jul 28, 2026

AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’

AstraZeneca's CEO, Pascal Soriot, emphasizes the need for Western pharmaceutical companies to adopt a faster pace of innovation, akin to that seen in China's rapidly advancing industry. He warns that without this shift, they risk falling behind more agile competitors, similar to the challenges faced by the Western automotive sector.Soriot's comments reflect a growing concern within the industry about the competitive landscape, particularly as China's pharmaceutical sector continues to innovate a
A minimalist representation of a single cell and gene strands in a dark palette.

Jul 28, 2026

Novogene Europe Adds Single-Cell Sequencing at Cambridge Omics Centre

Novogene Europe has enhanced its single-cell RNA sequencing capabilities at the Cambridge Omics Centre, providing advanced sequencing services to researchers in the UK.This development leverages Novogene's established expertise in single-cell technologies, integrating specialized project support, sequencing infrastructure, and bioinformatics analysis. The aim is to facilitate deeper biological insights from complex samples, responding to the increasing demand for accessible single-cell transcrip
Handheld diagnostic device for COPD testing on a wooden table in a clinical setting.

Jul 28, 2026

Tidalsense raises $19M for AI-powered COPD diagnostic platform

Tidalsense Ltd. has successfully secured $19 million in funding to advance its AI-driven diagnostic platform aimed at identifying chronic obstructive pulmonary disease (COPD).The company’s N-Tidal Diagnose platform offers a rapid diagnostic test that can detect COPD within five minutes. This innovative approach involves a simple procedure where users breathe normally into a handheld device for 75 seconds, capturing a carbon dioxide breath waveform. The data is then analyzed using artificial inte
A vial of medication on a laboratory shelf in a dimly lit setting.

Jul 27, 2026

AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’

AstraZeneca's CEO, Pascal Soriot, emphasizes the need for Western pharmaceutical companies to adopt a faster pace of innovation, akin to that of China's rapidly advancing drug industry. He warns that without this shift, they risk losing competitiveness, similar to the challenges faced by the Western automotive sector.Soriot highlighted AstraZeneca's commitment to achieving ambitious growth targets, aiming for $80 billion in annual sales by 2030. The company reported a 6% revenue increase in the
A minimalist chatbot icon on a lime background

Jul 27, 2026

ChapsVision aims to become Europe’s AI champion amid Palantir skepticism

ChapsVision is emerging as a significant player in Europe’s AI landscape, having recently replaced Palantir at France's domestic intelligence agency, DGSI, with its ArgonOS system.Founded in 2019, ChapsVision has rapidly expanded, now employing around 1,000 people and generating approximately €200 million in revenue for the fiscal year 2024/2025. This strategic shift is part of France's broader initiative to enhance digital sovereignty and reduce reliance on foreign technology, with the governme
Handheld diagnostic device for COPD testing on a wooden table in a clinical setting.

Jul 27, 2026

Tidalsense raises $19M for AI-powered COPD diagnostic platform

Tidalsense Ltd. has successfully secured $19 million in funding to advance its AI-driven diagnostic platform, N-Tidal Diagnose, aimed at detecting chronic obstructive pulmonary disease (COPD) swiftly and efficiently.The N-Tidal Diagnose platform utilizes a handheld device that captures a carbon dioxide breath waveform from users who breathe normally for 75 seconds. This data is then analyzed using artificial intelligence to provide a diagnosis of COPD in as little as five minutes. This innovatio
A radiologist examining a chest X-ray in a dimly lit room.

Jul 27, 2026

Why Aidoc is taking a generative AI device to the FDA

Aidoc is advancing its generative AI tool, First Read, towards FDA approval, highlighting its potential to transform radiology diagnostics.In June, the FDA granted Aidoc a breakthrough designation for First Read, a generative AI tool designed to analyze chest X-rays and produce reports for radiologists. This designation allows for expedited review, reflecting the FDA's ongoing exploration of generative AI applications in medical devices. Aidoc's system aims to identify over 100 diseases, providi
A minimalist representation of a drug capsule with a simulation graph.

Jul 27, 2026

AI Is Moving Pharma Commercialization from Prediction to Simulation

The landscape of pharmaceutical commercialization is shifting from retrospective analysis to proactive simulation, driven by advancements in artificial intelligence (AI).Traditionally, pharmaceutical companies relied on historical data to inform their commercial strategies, adjusting their approaches based on past performance. However, companies like Trinity are pioneering a new model where AI enables the simulation of potential behaviors of physicians, patients, and payers before making critica
Illustration of a single cell with RNA strands

Jul 27, 2026

Novogene Europe Adds Single-Cell Sequencing at Cambridge Omics Centre

Novogene Europe has enhanced its single-cell RNA sequencing capabilities at the Cambridge Omics Centre, making advanced sequencing workflows more accessible to researchers in the UK.This expansion leverages Novogene's expertise in single-cell analysis, integrating specialized project support, sequencing technologies, and bioinformatics to facilitate deeper biological insights from complex samples. The service addresses the increasing demand for single-cell transcriptomics, enabling researchers t
A minimalist illustration of a pill and bacteria in flat design.

Jul 27, 2026

Antares project launches: AI aims to accelerate search for new antibacterials

The Antares project, a collaborative initiative funded by the German Federal Ministry of Research, Technology and Space, aims to leverage artificial intelligence in the search for new antibiotics. This public-private partnership involves key players like the Fraunhofer ITMP, Helmholtz Centre for Infection Research, and Enamine Deutschland, focusing on developing effective treatments for drug-resistant infections.The project employs AI models trained on publicly accessible datasets to streamline
A flat silhouette of a healthcare shield representing decentralized health systems.

Jul 27, 2026

Coalition for Decentralized Healthcare and Life Sciences Recognized by United Nations Global Dialogue on AI Governance

The Coalition for Decentralized Healthcare and Life Sciences (CDHLS) has gained recognition from the United Nations as a significant initiative in the AI governance landscape, particularly in healthcare.This acknowledgment places CDHLS's initiative, “Decentralized Health Systems Adoption at Scale,” within three thematic areas of the UN Global Dialogue on AI Governance: Bridging AI Divides, Safe/Secure and Trustworthy AI, and Human Rights/Transparency and Oversight. The focus is on leveraging Dec
A stethoscope on a patient's chest in a dimly lit examination room.

Jul 27, 2026

AI-Driven Cardiac Diagnostics Market : Global Industry Analysis and Opportunity Assessment, 2036

The AI-driven cardiac diagnostics market is poised for significant growth, with projections indicating a rise from USD 903.2 million in 2026 to USD 2,805.1 million by 2036, driven by a compound annual growth rate (CAGR) of 12.0%. This surge is largely attributed to the increasing clinical demand for prompt risk identification and efficient interpretation of cardiac data.As cardiovascular diseases remain a leading cause of mortality, the need for advanced diagnostic tools that streamline ECG and